2型糖尿病患者におけるピオグリタゾン追加投与によるインスリン分泌促進薬減量の有効性と安全性
Efficacy and Safety in Reducing the Dosage of Insulin Secretagogues with Addition of Pioglitazone in Patients with Type 2 Diabetes

Hiroko Mori, Yosuke Okada, Akiko Yoshimura, Tadashi Arao, Keiko Nishida, Yoshiya Tanaka
2011 Journal of the Japan Diabetes Society  
doi:10.11213/tonyobyo.54.786 fatcat:3sprjylyajhyfiy2nfvttghsc4